Evidence-Based Veterinary Medicine Association

FDA Agrees Loyal Data Supports Reasonable Expectation of Effectiveness for Large Dog Lifespan Extension

Retrieved on: 
Tuesday, November 28, 2023
Health, FDA, Consumer, Pets, Pharmaceutical, Biotechnology, Veterinary, Great Dane, Longevity, Evidence-Based Veterinary Medicine Association, Safety, Food, Center for Veterinary Medicine, Ageing, Collection, Risk, Patient, Multimedia, Life, Veterinary medicine, Notifiable disease, Animal, Breeding, Evidence, Human, Doctor of Philosophy, VMD, Khosla Ventures, Cancer, Quality of life, Dog, Observational study, Pharmaceutical industry, Vaccine, Loyal

“Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs,” said Loyal CEO Celine Halioua.

Key Points: 
  • “Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs,” said Loyal CEO Celine Halioua.
  • It’s designed for drugs that demonstrate a reasonable expectation of effectiveness in addressing an unmet medical need, but require complex and difficult studies to complete collection of definitive effectiveness data.
  • It means the FDA agrees LOY-001 has a reasonable expectation of effectiveness and, once the FDA approves Loyal’s manufacturing and safety data packages, Loyal can market the drug for lifespan extension in the target canine population.
  • The Center for Veterinary Medicine at the FDA has reviewed Loyal’s data, results, and scientific arguments and determined they provide reasonable expectation of the drug’s effectiveness to extend canine lifespan and healthspan.

Stork Club Reproductive Benefits Solution Partners with Reproductive Medicine Associates (RMA) of New Jersey

Retrieved on: 
Wednesday, October 18, 2023
Science, Evidence-Based Veterinary Medicine Association, RMA, Stork Club, PGT, Reproductive medicine, IVF, Partnership, Medical assistant, Society, Patient, IUI, SAN, Nightclub, Birth control, Nursing

SAN FRANCISCO, Oct. 18, 2023 /PRNewswire/ -- Stork Club, a pioneering family-building benefits solution, today announced its partnership with Reproductive Medicine Associates (RMA) of New Jersey. The partnership gives Stork Club members access to best-in-class care at RMA's 11 clinic locations across New Jersey. The RMA Network currently operates 23 clinics across six states in the U.S.

Key Points: 
  • SAN FRANCISCO, Oct. 18, 2023 /PRNewswire/ -- Stork Club , a pioneering family-building benefits solution, today announced its partnership with Reproductive Medicine Associates (RMA) of New Jersey .
  • The partnership gives Stork Club members access to best-in-class care at RMA's 11 clinic locations across New Jersey.
  • This translates into Live Birth rates in New Jersey, where 8 out of 10 individuals who visit Reproductive Medicine Associates make their vision of parenthood a reality.
  • "Through our partnership with RMA of NJ, we empower our members with enhanced accessibility to exceptional care and outstanding outcomes."

Reproductive Medicine Associates Opens First Center in Houston and Expands Access to Outstanding Fertility Care for Texans

Retrieved on: 
Tuesday, February 28, 2023
Reproductive technology, Lone Star, IVF, Andrology, Ice cream, Patient, Fertility, Reproductive medicine, REI, Heart, Research, Journal, Ministry of Research, Innovation and Science, Evidence-Based Veterinary Medicine Association, Innovation, Suite, RMA, IUI, International Women's Day, International Women's Health Coalition, Embryology, Thomas Jefferson, Genetic testing, PGT, Yoga, Birth control, Medical device, Genetics, Infertility

HOUSTON, Feb. 28, 2023 /PRNewswire/ -- Reproductive Medicine Associates recently announced the opening of its newest fertility center in Houston, marking RMA's first expansion into the Lone Star State and adding to an extensive network of clinics around the country.

Key Points: 
  • Medical Director Nola Herlihy, M.D., has dedicated her career to building families through her practice and extensive fertility research with RMA.
  • Her research has been published in the Journal of Assisted Reproduction and Genetics, Fertility and Sterility and other peer-reviewed journals.
  • Individuals and couples worried about financing their fertility treatments should check whether their health insurance plan covers comprehensive reproductive services.
  • If fertility treatments are not covered by their insurer, many employers offer supplemental coverage through benefit providers like Progyny.

Reproductive Medicine Associates (RMA) Expands Access to Outstanding Fertility Care with New East Bay Location

Retrieved on: 
Monday, January 23, 2023
Physician, Northern California, Reproductive medicine, PGT, Innovation, Fertility, Central Valley, United States Congress, Evidence-Based Veterinary Medicine Association, RMA, IUI, Patient, SART, Infertility, Uterus, Assisted reproductive technology, Society, Polycystic ovary syndrome, Meta-Research Innovation Center at Stanford, IVF, Birth control, Nursing

SAN FRANCISCO, Jan. 23, 2023 /PRNewswire/ -- Reproductive Medicine Associates (RMA) of California announced last week the opening of its newest fertility center in East Bay. The center marks the third RMA location in Northern California, joining San Francisco and Palo Alto, adding to an extensive network of clinics throughout the state and around the country.

Key Points: 
  • "We are so excited to open an office closer to our patients in the East Bay.
  • Dr. Morin is joined in the East Bay clinic by Alice Shapiro, M.D., a reproductive endocrinologist and Fellow of The American Congress of Obstetricians and Gynecologists.
  • For individuals and couples worried about financing their fertility treatments, they should check whether their health insurance plan covers comprehensive reproductive services.
  • If fertility treatments are not covered by their insurer, many employers offer supplemental coverage through benefit providers like Progyny.

Groundbreaking PGT-A Genetic Test Research Receives Prestigious Investigator Achievement Award

Retrieved on: 
Thursday, November 3, 2022
Transfer, Doctor of Philosophy, American Society for Reproductive Medicine, Genetic testing, Technology, Embryo, Mosaic, DNA, Research, IVF, Aneuploidy, Education, Pregnancy, Multimedia, Society, COO, Genetics, RMA, Cell, Safety, Knowledge, ASRM, Biopsy, Reproductive medicine, Sterility, Juno, Health, Attention, Episcopal conference, View, Evidence-Based Veterinary Medicine Association, Diagnosis, SET, Patient, MD, PGT, Medical device, Medicine, Fertility

BASKING RIDGE, N.J., Nov. 3, 2022 /PRNewswire/ -- The top journal in the field of reproductive medicine, Fertility and Sterility, has named Julia Kim, MD, winner of its 2022 Investigator Achievement Award. Dr. Kim is first author of a landmark study on preimplantation genetic testing for aneuploidy (PGT-A). The research was conducted in collaboration with Juno Genetics during her fellowship at Reproductive Medicine Associates (RMA), part of the IVIRMA fertility network. The prestigious award recognizes an exceptional paper in which the first author is less than five years out of fellowship training or less than 35 years old. The award was recently presented to Dr. Kim at the American Society for Reproductive Medicine (ASRM) Scientific Congress in Anaheim, California.

Key Points: 
  • The prestigious award recognizes an exceptional paper in which the first author is less than five years out of fellowship training or less than 35 years old.
  • The award was recently presented to Dr. Kim at the American Society for Reproductive Medicine (ASRM) Scientific Congress in Anaheim, California.
  • The study assessed the reproducibility of the clinical result as an indicator of test accuracy.
  • "The research for which I am receiving the award would not have been possible without the combined efforts of an incredible team at IVIRMA and Juno Genetics.

Dr. Alan Copperman Recognized as a Notable Health Care Leader by Crain's New York Business 2022

Retrieved on: 
Monday, August 22, 2022
Icahn School of Medicine at Mount Sinai, COVID-19, Fertility preservation, Patient, Reproductive medicine, CEO, Division, Health minister, Obstetrics & Gynecology (journal), Vaccination, Research, Genetics, Infertility, Health (magazine), Physician, Yale New Haven Hospital, RMA, IVF, Multimedia, Evidence-Based Veterinary Medicine Association, Medical director, Fertility, Obstetrics and gynaecology, U.S. News & World Report, Genomics, Industry, Growth, Health, CBS, Pharmaceutical industry, Birth control, Obstetrics, New York (magazine), The New York Times, Gynaecology

NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Reproductive Medicine Associates of New York (RMA of New York) is proud to announce that Dr. Alan Copperman has been named one of Crain's New York Business 2022 Notable Health Care Leaders for his extensive contributions to the field of reproductive medicine.

Key Points: 
  • NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Reproductive Medicine Associates of New York (RMA of New York) is proud to announce that Dr. Alan Copperman has been named one of Crain's New York Business 2022 Notable Health Care Leaders for his extensive contributions to the field of reproductive medicine.
  • As a leader in the field, Dr. Copperman is widely recognized for prioritizing research and innovation to improve patient outcomes.
  • Dr. Copperman's recognition from Crain's comes at a particularly notable juncture in the delivery of reproductive health services in the United States.
  • For more information about Crain's New York Business 2022 Notable Health Care Leaders, visit www.crainsnewyork.com .

TexPTS and SMASA Partnership Bolsters Sports Physical Therapy Management and Operations

Retrieved on: 
Tuesday, August 2, 2022
Sports medicine, University, PTPN, Education, Physician, SAN, Fellow, Research, Partnership, Injury, Marketing, Board, Evidence-Based Veterinary Medicine Association, Family, OCS, Trinity University, Occupational therapy, Spur, Facebook, MS, Director, Technology, MBA, MD, Ecosystem, Patient, PT, Health, St. Mary's, European Federation of Sports Medicine Associations, Growth, San Antonio Spurs, Dentistry, Medicine

SAN ANTONIO, Aug. 2, 2022 /PRNewswire-PRWeb/ -- Sports Medicine Associates of San Antonio (SMASA), a team of Board-certified orthopedic surgeons and sports medicine primary care physicians committed to providing quality care, is proud to announce their joint venture with Texas Physical Therapy Specialists (TexPTS). This venture solidifies TexPTS' operations of 4 SMASA physical therapy clinics and SMASA's 7 total locations, further expanding the groups' footprint across San Antonio, Austin and greater Texas.

Key Points: 
  • This venture solidifies TexPTS' operations of 4 SMASA physical therapy clinics and SMASA's 7 total locations, further expanding the groups' footprint across San Antonio, Austin and greater Texas.
  • This venture will allow SMASA to maintain its existing brands while gaining access to TexPTS' parent company's, Confluent Health, ecosystem of management services, education, and musculoskeletal health innovations.
  • Roggia previously served as Director of TexPTS SMASA and will now be running all operations for the venture.
  • Texas Physical Therapy Specialists (TexPTS) is a Texas-based, private physical therapy practice group.

Infertility Awareness Nonprofit Partners with Reproductive Medicine Associates to Address Disparities in Treatment by Offering IVF Grants to People of Color

Retrieved on: 
Wednesday, June 22, 2022
Transfer, Fertility, Reproductive medicine, Education, Evidence-Based Veterinary Medicine Association, Safety, Dream, Genetics, Infertility, Reproductive health, Knowledge, Embryo, Research, SET, RMA, Travel, Color, Partnership, IVF, Patient, Genetic testing, Diagnosis, Awareness, Woman, Birth control

"This grant program aims to address those obstacles and disparities and help achieve the dreams of those wishing to build their families."

Key Points: 
  • "This grant program aims to address those obstacles and disparities and help achieve the dreams of those wishing to build their families."
  • Additionally, FFCG seeks to empower African American women to take charge of their fertility and reproductive health.
  • Reproductive Medicine Associates (RMA) has been helping build families through the most advanced treatment options and patient-centered fertility care for over 20 years.
  • Juno genetics is dedicated to advancing knowledge and enhancing outcomes in embryonic research, diagnosis, and education.

RMA of New York Opens State-of-the-Art IVF Laboratory in Brooklyn, expanding access to fertility care to New York's most populous county

Retrieved on: 
Tuesday, December 14, 2021
Mount Sinai, Department of Obstetrics and Gynecology (Massachusetts General Hospital), IUI, Hudson Valley, Physician, Mandarin Oriental Hotel Group, Fertility, IVF, Icahn School of Medicine at Mount Sinai, City, Infertility, Research, Patient, Reproductive medicine, Department, RMA, Freezing, Division, Partnership, Evidence-Based Veterinary Medicine Association, PGT, Precision medicine, Artificial insemination, Birth control, Obstetrics, Gynaecology, Medicine, New York (magazine)

The center, easily accessible to all Brooklyn residents, is the newest of RMA of New York's 13 offices, and its fourth IVF laboratory site.

Key Points: 
  • The center, easily accessible to all Brooklyn residents, is the newest of RMA of New York's 13 offices, and its fourth IVF laboratory site.
  • For the past 10 years, RMA of New York had served the Brooklyn community at a satellite office in downtown Brooklyn.
  • The opening of this new, full-service center, enhanced with an onsite state-of-the-art IVF laboratory, allows Brooklyn residents to meet all of their fertility needs in one location.
  • Personalized, precision medicine and clinical excellence have been hallmark characteristics of RMA of New York for the past 20 years.

Reproductive Medicine Associates of New York Presents Innovative Research at ASRM's 77th Annual Meeting

Retrieved on: 
Tuesday, October 19, 2021
Fertility preservation, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Woman, Infertility, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Intelligence, CDC, Associate, LLP, Center, COVID-19, Gynaecology, Society, Centers for Disease Control and Prevention timeline, RMA, Pregnancy, Congress, IVF, Multimedia, Department, Research, Evidence-Based Veterinary Medicine Association, Reproductive medicine, Obstetrics, Fertility, Vaccine, ASRM, Division, Insurance, American Society for Reproductive Medicine, Patient, Assisted reproductive technology, SART, RNA transfection, DNA, Pharmaceutical industry

BALTIMORE, Md., Oct. 19, 2021 /PRNewswire/ --Physicians and scientists at Reproductive Medicine Associates of New York (RMA of New York) and the Icahn School of Medicine at Mount Sinai Hospital in New York presented a record 35 original scientific abstracts at the 77th annual meeting of the American Society for Reproductive Medicine (ASRM) in Baltimore, Maryland.

Key Points: 
  • BALTIMORE, Md., Oct. 19, 2021 /PRNewswire/ --Physicians and scientists at Reproductive Medicine Associates of New York (RMA of New York) and the Icahn School of Medicine at Mount Sinai Hospital in New York presented a record 35 original scientific abstracts at the 77th annual meeting of the American Society for Reproductive Medicine (ASRM) in Baltimore, Maryland.
  • Research topics included single cell DNA sequencing, disparities in health care outcomes, and the impact of the COVID-19 pandemic on the patient journey.
  • Her research on single cell sequencing of whole human blastocystsexpands our current understanding of the genetic composition of human embryos.
  • About Reproductive Medicine Associates of New York, LLP
    Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a global leader in state-of-the-art reproductive medicine.